Novo Nordisk has signed a deal worth up to $1bn with Lexicon Pharmaceuticals for the exclusive global rights to oral therapy ...

The new recipients of 23andMe’s data would not necessarily have to offer consumers the ability to opt out once they take possession of it. And it remains unclear which (or how many) hands the data ...

With the changes, manufacturers will be allowed to increase the maximum retail price (MRP) of scheduled formulations on the ...

Value stocks aren't typically the most exciting investments, but they can often provide steady capital gains without causing investors to lose any sleep during periods of market volatility.

Arizona AG urges eligible consumers to claim compensation from a $39.1 million Apotex settlement over inflated generic drug ...

As U.S. President Donald Trump threatens a new round of tariffs as part of an onshoring push, Chinese President Xi Jinping is ...

The Board of Investment highlighted Thailand’s strategic advantages as it seeks to position itself as a regional hub for high ...

Jack Chambers rules out public spending cuts but stresses the need for careful financial planning amid tariff threats ...

The ongoing investigation by Wyden and his Democratic compatriots from the Finance Committee has pointed the finger at ...

Spread the love Introduction The biotechnology industry continues to be at the forefront of scientific innovation, driving ...

Though the first chapter of Adult Swim’s Common Side Effects animated series is about to wrap up this Sunday, the story isn’t ...

Learn more about Ascentage Pharma Group International's (AAPG) stock grades for Value and Growth and determine whether this Biotechnology stock meets your investment needs.